Gold nanoparticle surface functionalization: A necessary requirement in the development of novel nanotherapeutics

Nanomedicine

Volumn 10, Issue 8, 2015, Pages 1315-1326

  Nicol, James R ^a   Dixon, Dorian ^b   Coulter, Jonathan A ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

bottom up synthesis; gold; nanoparticle; nanoparticle functionalization; nanoparticle stability; organelle targeting

Indexed keywords

ANTINEOPLASTIC AGENT; GOLD NANOPARTICLE; GOLD; METAL NANOPARTICLE;

CLINICAL TRIAL (TOPIC); DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG STABILITY; DRUG SYNTHESIS; HUMAN; NANOPHARMACEUTICS; PARTICLE SIZE; PRIORITY JOURNAL; RADIOSENSITIZATION; REVIEW; SURFACE PROPERTY; ANIMAL; CHEMISTRY; NANOMEDICINE; NANOTECHNOLOGY; NEOPLASMS; PROCEDURES; ULTRASTRUCTURE;

ANIMALS; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEMS; GOLD; HUMANS; METAL NANOPARTICLES; NANOMEDICINE; NANOTECHNOLOGY; NEOPLASMS;

EID: 84929072773     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.14.219     Document Type: Review

References (81)

1. Praetorius NP, Mandal TK. Engineered nanoparticles in cancer therapy. Recent Pat. Drug Deliv. Formul. 1(1), 37-51 (2007).
2. Fang RH, Hu C-MJ, Luk BT et al. Cancer cell membranecoated nanoparticles for anticancer vaccination and drug delivery. Nano Lett. 14(4), 2181-2188 (2014).
3. Hainfeld JF, Smilowitz HM, O'Connor MJ, Dilmanian FA, Slatkin DN. Gold nanoparticle imaging and radiotherapy of brain tumors in mice. Nanomedicine 8(10), 1601-1609 (2012).
4. Numnuam A, Thavarungkul P, Kanatharana P. An amperometric uric acid biosensor based on chitosan-carbon nanotubes electrospun nanofiber on silver nanoparticles. Anal. Bioanal. Chem. 406(15), 3763-3772 (2014).
5. Miladi I, Alric C, Dufort S. The in vivo radiosensitizing effect of gold nanoparticles based MRI contrast agents. Small 10(6), 1116-24 (2014).
6. Libutti SK, Paciotti GF, Byrnes AA et al. Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine. Clin. Cancer Res. 16(24), 6139-6149 (2010).
7. Gad SC, Sharp KL, Montgomery C, Payne JD, Goodrich GP. Evaluation of the toxicity of intravenous delivery of auroshell particles (gold-silica nanoshells). Int. J. Toxicol. 31(6), 584-94 (2013).
8. Regulla DF, Hiebert LB, Seidenbusch M. Physical and biological interface dose effects in tissue due to x-ray-from metallic gold surfaces induced release of secondary radiation. Radiat. Res. 150(17), 92-100 (1998).
9. Herold DM, Das I, Stobbe CC, Lyer RV, Chapman JD. Gold microspheres: a selective technique for producing biologically effective dose enhancement. J. Radiat. 76(10), 1357-64 (2000).
10. Turkevitch J, Stevenson PC, Hillier J. A study of the nucleation and growth processes in the synthesis of colloidal gold. Discuss. Faraday Soc. 11(c), 55-75 (1951).
11. Frens G. Controlled nucleation for the regulation of the particle size in monodisperse gold suspensions. Nat. Phys. Sci. 241, 20-22 (1973).
12. Juurinen I, Pylkka T. Effect of the hydrophobic alcohol chain length on the hydrogen-bond network of water. J. Phys. Chem. 118(29), 8750-8755 (2014).
13. Kumar D, Meenan BJ, Mutreja I, D'Sa R, Dixon D. Controlling the size and size distribution of gold nanoparticles: a design of experiment study. Int. J. Nanosci. 11(2), 1250023 (2012).
14. Ojea-jime I, Romero FM, Bastu NG, Puntes V. Small gold nanoparticles synthesized with sodium citrate and heavy water: insights into the reaction mechanism. J. Phys. Chem. 114, 1800-1804 (2010).
15. Okitsu K, Sharyo K, Nishimura R. One-pot synthesis of gold nanorods by ultrasonic irradiation: the effect of pH on the shape of the gold nanorods and nanoparticles. Langmuir 25(14), 7786-7790 (2009).
16. Ueda J, Nakamura A, Cho S, Saito N, Takai O. Gold nanoparticle synthesis using three-dimensionally integrated micro-solution plasmas. Jpn. J. Appl. Phys. 52, 126202 (2013).
17. Philip D. Green synthesis of gold and silver nanoparticles using Hibiscus rosa sinensis. Phys. E Low Dimens. Syst. Nanostruct. 42(5), 1417-1424 (2010).
18. Zhou M, Wang B, Rozynek Z et al. Minute synthesis of extremely stable gold nanoparticles. Nanotechnology 20(50), 505606 (2009).
19. Brust M, Walker M, Bethell D, Schiffrin DJ, Whyman R. Synthesis of thiol-derivatised gold nanoparticles in. J. Chem. Soc. Chem. Commun. 7, 801-802 (1994).
20. Zhao P, Li N, Astruc D. State of the art in gold nanoparticle synthesis. Coord. Chem. Rev. 257, 638-665 (2013).
21. Li Y, Zaluzhna O, Xu B, Gao Y, Modest JM, Tong YJ. Mechanistic insights into the Brust-Schiffrin twophase synthesis of organo-chalcogenate-protected metal nanoparticles. J. Am. Chem. Soc. 133(7), 2092-2095 (2011).
22. Farren-Dai M, Awoonor-Williams E, MacNeil CS, Mahimwalla Z, Ghandi K. A novel gold nanoparticle stabilization and its muon chemistry. Chem. Phys. Lett. 610, 610-611, 331-334 (2014).
23. Ye X, Jin L, Caglayan H et al. Improved size-tunable synthesis of monodisperse gold nanorods through the use of aromatic additives. ACS Nano 6(3), 2804-2817 (2012).
24. Cho W-S, Cho M, Jeong J et al. Size-dependent tissue kinetics of PEG-coated gold nanoparticles. Toxicol. Appl. Pharmacol. 245(1), 116-123 (2010).
25. Kumar D, Meenan BJ, Dixon D. Glutathione-mediated release of Bodipy® from PEG cofunctionalised gold nanoparticles. Int. J. Nanomed. 7, 4007-4022 (2012).
26. Kingston D, Cao S, Zhao J, Paciotti G, Hubta M: US8558019B2 (2013).
27. Nativo P, Porta F, Brust M. A multidentate peptide for stabilization and facile bioconjugation of gold. Bioconjug. Chem. 20, 619-624 (2009).
28. Slocik JM, Govorov AO, Naik RR. Plasmonic circular dichroism of peptide-functionalised. Nano Lett. 11, 701-705 (2011).
29. Tsai D-H, Cho TJ, Elzey SR, Gigault JC, Hackley VA. Quantitative analysis of dendron-conjugated cisplatincomplexed gold nanoparticles using scanning particle mobility mass spectrometry. Nanoscale 5(12), 5390-5395 (2013).
30. Mirkin CA. Gold nanoparticles for biology and medicine. J. Nanobiotechnol. 49(19), 3280-3294 (2014).
31. Gupta RK, Srinivasan MP, Dharmarajan R. Synthesis of 16-mercaptohexadecanoic acid capped gold nanoparticles and their immobilization on a substrate. Mater. Lett. 67(1), 315-319 (2012).
32. Stobiecka M, Coopersmith K, Hepel M. Resonance elastic light scattering (RELS) spectroscopy of fast non-Langmuirian ligand-exchange in glutathione-induced gold nanoparticle assembly. J. Colloid Interface Sci. 350(1), 168-177 (2010).
33. Astruc D, Liang L, Rapakousiou A, Ruiz J. Click dendrimers and triazole-related aspects: catalysts, mechanism, synthesis, and functions. A bridge between dendritic architectures and nanomaterials. Acc. Chem. Res. 45(4), 630-640 (2012).
34. Boisselier E, Diallo AK, Salmon L, Ornelas C, Ruiz J, Astruc D. Encapsulation and stabilization of gold nanoparticles with 'click' polyethyleneglycol dendrimers. J. Am. Chem. Soc. 132(8), 2729-2742 (2010).
35. Song Y, Xu X, MacRenaris KW, Zhang X-Q, Mirkin CA, Meade TJ. Multimodal gadolinium-enriched DNA-gold nanoparticle conjugates for cellular imaging. Angew. Chem. Int. Ed. Engl. 48(48), 9143-9147 (2009).
36. Bishop KJM, Wilmer CE, Soh S, Grzybowski B. Nanoscale forces and their uses in self-assembly. Small 5(14), 1600-1630 (2009).
37. Huang X, Peng X, Wang Y et al. A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalalently conjugated peptide ligands. ACS Nano 4(10), 5887-5896 (2010).
38. Kirui DK, Rey DA, Batt CA. Gold hybrid nanoparticles for targeted phototherapy and cancer imaging. Nanotechnology 21(10), 105105 (2010).
39. Blood R, Counts C, Simpson CA et al. Short-chain PEG mixed monolayer protected gold clusters increases clearance and red blood cell counts. ACS Nano 5(5), 3577-3584 (2011).
40. Paciotti GF, Kingston DGI, Tamarkin L. Colloidal gold nanoparticles: a novel nanoparticle platform for developing multifunctional tumor-targeted drug delivery vectors. Drug Dev. Res. 67(1), 47-54 (2006).
41. Brown SD, Nativo P, Smith J-A et al. Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin. J. Am. Chem. Soc. 132(13), 4678-84 (2010).
42. Dreaden EC, Mwakwari SC, Sodji QH, Oyelere AK, El-Sayed MA. Tamoxifen-poly(ethylene glycol)-thiol gold nanoparticle conjugates: enhanced potency and selective delivery for breast cancer treatment. Bioconjug. Chem. 20(12), 2247-53 (2009).
43. Li SD, Huang L. Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting. J. Control. Release. 145(3), 178-181 (2011).
44. Fang J, Nakamura H, Maeda H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv. Drug Deliv. Rev. 63(3), 136-151 (2011).
45. Wang M, Thanou M. Targeting nanoparticles to cancer. Pharmacol. Res. 62(2), 90-99 (2010).
46. Hao Y, Yang X, Song S et al. Exploring the cell uptake mechanism of phospholipid and polyethylene glycol coated gold nanoparticles. Nanotechnology 23(4), 045103 (2012).
47. Chen H, Paholak H, Ito M et al. 'Living' PEGylation on gold nanoparticles to optimize cancer cell uptake by controlling targeting ligand and charge densities. Nanotechnology 24(35), 355101 (2013).
48. Liu T, Thierry B. A solution to the PEG dilemma: efficient bioconjugation of large gold nanoparticles for biodiagnostic applications using mixed layers. Langmuir 28(44), 15634-15642 (2012).
49. Liu X, Huang H, Jin Q, Ji J. Mixed charged zwitterionic selfassembled monolayers as a facile way to stabilize large gold nanoparticles. Langmuir 27(9), 5242-5251 (2011).
50. Herd H, Daum N, Jones AT, Huwer H, Ghandehari H, Lehr CM. Nanoparticle geometry and surface orientation influence mode of cellular uptake. ACS Nano 7(3), 1961-1973 (2013).
51. Coulter JA, Jain S, Butterworth KT et al. Cell typedependent uptake, localization, and cytotoxicity of 1.9 nm gold nanoparticles. Int. J. Nanomed. 7, 2673-2685 (2012).
52. Trono JD, Mizuno K, Yusa N, Matsukawa T, Yokoyama K, Uesaka M. Size, concentration and incubation time dependence of gold nanoparticle uptake into pancreas cancer cells and its future application to x-ray drug delivery system. J. Radiat. Res. 52(1), 103-109 (2011).
53. Peckys DB, Jonge N De. Gold nanoparticle uptake in whole cells in liquid examined by environmental scanning electron microscopy. Microsc. Microanal. 20(1), 189-197 (2014).
54. Yuan H, Fales AM, Vo-Dinh T. TAT peptide-functionalised gold nanostars: enhanced intracellular delivery and efficient NIR photothermal therapy using ultralow irradiance. J. Am. Chem. Soc. 134(28), 11358-11361 (2012).
55. Fales AM, Yuan H, Vo-Dinh T. Cell-penetrating peptide enhanced intracellular Raman imaging and photodynamic therapy. Mol. Pharm. 10(6), 2291-2298 (2013).
56. Oh E, Delehanty JB, Sapsford KE. Cellular uptake and fate of PEGylated gold nanoparticles is dependent on both cell-penetration peptides and particle size. ACS Nano 5(8), 6434-6448 (2011).
57. Stuchinskaya T, Moreno M, Cook MJ, Edwards DR, Russell DA. Targeted photodynamic therapy of breast cancer cells using antibody-phthalocyanine-gold nanoparticle conjugates. Photochem. Photobiol. Sci. 10(5), 822-831 (2011).
58. Wang Y, Chen J, Irudayaraj J. Nuclear targeting dynamics of gold nanoclusters for enhanced therapy of HER2+ breast cancer. ACS Nano 5(12), 9718-25 (2011).
59. Marega R, Karmani L, Flamant L et al. Antibodyfunctionalised polymer-coated gold nanoparticles targeting cancer cells: an in vitro and in vivo study. J. Mater. Chem. 22(39), 21305 (2012).
60. Reuveni T, Motiei M, Romman Z, Popovtzer A, Popovtzer R. Targeted gold nanoparticles enable molecular CT imaging of cancer: an in vivo study. Int. J. Nanomed. 6, 2859-2864 (2011).
61. Bartczak D, Nitti S, Millar TM, Kanaras AG. Exocytosis of peptide functionalised gold nanoparticles in endothelial cells. Nanoscale 4(15), 4470-4472 (2012).
62. Chithrani BD, Stewart J, Allen C, Jaffray DA. Intracellular uptake, transport, and processing of nanostructures in cancer cells. Nanomed. Nanotechnol. Biol. Med. 5(2), 118-127 (2009).
63. Lévy R, Shaheen U, Cesbron Y, Sée V. Gold nanoparticles delivery in mammalian live cells: a critical review. Nano Rev. 1, 1-18 (2010).
64. See V, Free P, Cesbron Y et al. Cathepsin L digestion of nanobioconjugates upon endocytosis. ACS Nano 3(9), 2461-2468 (2009).
65. Krpeti Z, Saleemi S, Prior IA, Sée V, Qureshi R, Brust M. Negotiation of intracellular membrane barriers by TATmodified gold nanoparticles. ACS Nano 5(6), 5195-5201 (2011).
66. Martens TF, Remaut K, Demeester J, De Smedt SC, Braeckmans K. Intracellular delivery of nanomaterials: how to catch endosomal escape in the act. Nano Today 9(3), 344-364 (2014).
67. El-Sayed A, Futaki S, Harashima H. Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment. AAPS J. 11(1), 13-22 (2009).
68. Ju E, Li Z, Liu Z, Ren J, Qu X. Near-infrared light-triggered drug-delivery vehicle for mitochondria-targeted chemophotothermal therapy. ACS Appl. Mater. Interfaces 6(6), 4364-4370 (2014).
69. Wang L, Liu Y, Li W et al. Selective targeting of gold nanorods at the mitochondria of cancer cells: implications for cancer therapy. Nano Lett. 11(2), 772-80 (2011).
70. Roa W, Zhang X, Guo L et al. Gold nanoparticle sensitize radiotherapy of prostate cancer cells by regulation of the cell cycle. Nanotechnology 20(37), 375101 (2009).
71. Xu W, Luo T, Li P et al. RGD-conjugated gold nanorods induce radiosensitization in melanoma cancer cells by downregulating αvβ3 expression. Int. J. Nanomed. 7, 915-924 (2012).
72. Mackey MA, El-Sayed MA. Chemosensitization of cancer cells via gold nanoparticle-induced cell cycle regulation. Photochem. Photobiol. 90(2), 306-312 (2014).
73. Li X, Takashima M, Yuba E, Harada A, Kono K. PEGylated PAMAM dendrimer-doxorubicin conjugate-hybridized gold nanorod for combined photothermal-chemotherapy. Biomaterials 35(24), 6576-84 (2014).
74. Vives E, Brodin P, Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272(25), 16010-16017 (1997).
75. Derossit D, Prochiantztn M. The third helix of the antennapedia homeodornain translocates through biological membranes. J. Biol. Chem. 269(14), 10444-10450 (1994).
76. Rothbard JB, Garlington S, Lin Q et al. Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation. Nature 6(11), 1253-1257 (2000).
77. Pooga M, Hallbrink M, Zorko M, Langel U. Cell penetration by transportan. FASEB J. 12, 67-77 (1998).
78. Liu Y, Shipton MK, Ryan J, Kaufman ED, Franzen S, Feldheim DL. Synthesis, stability, and cellular internalization of gold nanoparticles containing mixed peptide-poly(ethylene glycol) monolayers. Anal. Chem. 79(6), 2221-2229 (2007).
79. Oehlke J, Scheller A, Wiesner B et al. Cellular uptake of an a-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically. Biochim. Biophys. Acta 1414, 127-139 (1998).
80. Abidi W, Selvakannan PR, Guillet Y et al. One-pot synthesis of gold nanorods and their optical properties. J. Phys. Chem. 114, 14794-14803 (2010).
81. Murphy CJ, Thompson LB, Chernak DJ et al. Gold nanorod crystal growth: from seed-mediated synthesis to nanoscale sculpting. Curr. Opim. Colloid Interface Sci. 16(2), 128-134 (2011).